Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Allovir Inc
ALVRCurrent price
10.19 USD
+0.93 USD (+10.04%)
Last closed
9.20 USD
Company
www.allovir.com
ISIN
US0198181036
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
85 254 840 USD
Yield for 12 month
+1 420.67 %
1Y
3Y
5Y
10Y
15Y
ALVR
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. The company was incorporated in 2013 and is based in Waltham, Massachusetts. Address: 1100 Winter Street, Waltham, MA, United States, 02451
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.20 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-398 000 USD
Last Year
-2 565 000 USD
Current Quarter
–
Last Quarter
–
Key Figures ALVR
1 year
3 years
5 years
10 years
EBITDA
-120 465 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-36.53 %
PEG Ratio
–
Return On Equity TTM
-80.33 %
Wall Street Target Price
1.20 USD
Revenue TTM
–
Book Value
1.06 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
165 000 USD
Earnings per share
-0.90 USD
Diluted Eps TTM
-0.90 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ALVR
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ALVR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ALVR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.37
Price Book MRQ
0.43
Financials ALVR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALVR
For 52 weeks
0.40 USD
2.42 USD
50 Day MA
0.81 USD
Shares Short Prior Month
1 221 814
200 Day MA
0.77 USD
Short Ratio
26.44
Shares Short
1 923 714
Short Percent
7.85 %
BeatStart